Quick Answer
Axogen, Inc. reported Total Revenue of $225.21 million for fiscal year 2025.
Axogen, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $225.21M +20.2% |
$187.34M +17.8% |
$159.01M +14.7% |
$138.58M +8.8% |
$127.36M +13.4% |
$112.30M +5.2% |
| Net Income | -$15.70M -57.6% |
-$9.96M +54.1% |
-$21.72M +25.0% |
-$28.95M -7.3% |
-$26.98M -13.4% |
-$23.79M +18.4% |
| Diluted EPS | -$0.34 -47.8% |
-$0.23 +54.9% |
-$0.51 +26.1% |
-$0.69 -6.2% |
-$0.65 -8.3% |
-$0.60 +18.9% |
| Total Assets | $221.69M +8.8% |
$203.73M +3.5% |
$196.83M +0.7% |
$195.39M -6.1% |
$208.02M +3.3% |
$201.38M +30.2% |
| Cash and Equivalents | $35.55M +29.0% |
$27.55M -11.2% |
$31.02M +103.0% |
$15.28M -53.3% |
$32.76M -32.8% |
$48.77M +36.5% |
| Long-Term Debt | $48.39M +1.9% |
$47.50M +1.9% |
$46.60M +1.9% |
$45.71M +2.0% |
$44.82M +39.9% |
$32.03M |
| Stockholders Equity | $128.85M +24.0% |
$103.91M +8.6% |
$95.67M -5.3% |
$101.00M -10.3% |
$112.55M -8.6% |
$123.15M -6.8% |
| R&D Expense | $32.88M +18.4% |
$27.77M +1.6% |
$27.34M +6.7% |
$25.63M +6.0% |
$24.18M +35.5% |
$17.85M +1.9% |
| Operating Income | -$7.85M -138.8% |
-$3.29M +84.7% |
-$21.46M +27.8% |
-$29.71M -16.9% |
-$25.42M -9.6% |
-$23.18M +26.2% |
| Gross Profit | $167.35M +17.9% |
$141.98M +16.5% |
$121.87M +12.0% |
$108.81M +4.2% |
$104.43M +15.1% |
$90.72M +1.5% |
| Shares Outstanding | 47.20M +6.9% |
44.15M +2.4% |
43.12M +1.6% |
42.45M +1.7% |
41.74M +2.8% |
40.62M +2.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $60.08M | +23.5% | +6.0% |
| Net Income | September 30, 2025 | $708.0K | +138.1% | +22.3% |
| Diluted EPS | September 30, 2025 | $0.01 | +125.0% | +0.0% |
| Total Assets | September 30, 2025 | $216.40M | +12.7% | +5.3% |
| Cash and Equivalents | September 30, 2025 | $23.90M | +28.1% | +19.3% |
| Long-Term Debt | September 30, 2025 | $48.16M | +1.9% | +0.5% |
| Stockholders Equity | September 30, 2025 | $120.81M | +21.5% | +7.6% |
| R&D Expense | September 30, 2025 | $7.57M | +8.1% | +10.4% |
| Operating Income | September 30, 2025 | $1.91M | +705.1% | +14.4% |
| Gross Profit | September 30, 2025 | $45.99M | +26.2% | +9.5% |
| Shares Outstanding | September 30, 2025 | 46.12M | +4.8% | +0.8% |
- Axogen, Inc. reported Total Revenue of $225.21 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +20.2% in Total Revenue compared to the prior fiscal year.
- Axogen, Inc. reported Net Income of -$15.70 million for fiscal year 2025.
- Axogen, Inc. showed a decrease of -57.6% in Net Income compared to the prior fiscal year.
- Axogen, Inc. reported Diluted EPS of $0.34 per share (loss) for fiscal year 2025.
- Axogen, Inc. showed a decrease of -47.8% in Diluted EPS compared to the prior fiscal year.
- Axogen, Inc. reported Total Assets of $221.69 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +8.8% in Total Assets compared to the prior fiscal year.
- Axogen, Inc. reported Cash and Equivalents of $35.55 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +29.0% in Cash and Equivalents compared to the prior fiscal year.
- Axogen, Inc. reported Long-Term Debt of $48.39 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +1.9% in Long-Term Debt compared to the prior fiscal year.
- Axogen, Inc. reported Stockholders Equity of $128.85 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +24.0% in Stockholders Equity compared to the prior fiscal year.
- Axogen, Inc. reported R&D Expense of $32.88 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +18.4% in R&D Expense compared to the prior fiscal year.
- Axogen, Inc. reported Operating Income of -$7.85 million for fiscal year 2025.
- Axogen, Inc. showed a decrease of -138.8% in Operating Income compared to the prior fiscal year.
- Axogen, Inc. reported Gross Profit of $167.35 million for fiscal year 2025.
- Axogen, Inc. showed an increase of +17.9% in Gross Profit compared to the prior fiscal year.
- Axogen, Inc. reported Shares Outstanding of 47.20 million shares for fiscal year 2025.
- Axogen, Inc. showed an increase of +6.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: